M&A Deal Summary

McKesson Acquires Medical Advisory Service for Travellers Abroad

On September 18, 2015, McKesson acquired medical products company Medical Advisory Service for Travellers Abroad from UDG Healthcare

Acquisition Highlights
  • This is McKesson’s 5th transaction in the Medical Products sector.
  • This is McKesson’s 2nd transaction in the United Kingdom.

M&A Deal Summary

Date 2015-09-18
Target Medical Advisory Service for Travellers Abroad
Sector Medical Products
Buyer(s) McKesson
Sellers(s) UDG Healthcare
Deal Type Divestiture

Target

Medical Advisory Service for Travellers Abroad

Leeds, United Kingdom
website
MASTA is a service provider in the travel health field, specialising in the sale and distribution of vaccines, medical information and clinical services. MASTA, based in Leeds, employs 60 people and sells direct to the medical profession occupational health departments of large organisations, and through MASTA branded travel clinics throughout the UK. The Company has a long established high quality reputation for the provision of a comprehensive range of services to all parties involved in the vaccines market.

Search 193,502 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

McKesson

Irving, Texas, United States

website


Category Company
Founded 1833
Sector Information Technology
Employees58,000
Revenue 264.0B USD (2022)
DESCRIPTION
McKesson office in The Woodlands, Texas.
McKesson office in The Woodlands, Texas.

McKesson is a health care services and information technology company. McKesson helps its customers improve their financial, operational, and clinical performance with solutions that include pharmaceutical and medical-surgical supply management, health care information technology, and business and clinical services. McKesson was founded in 1833 and is based in Irving, Texas.


DEAL STATS #
Overall 40 of 51
Sector (Medical Products) 5 of 8
Type (Divestiture) 7 of 10
Country (United Kingdom) 2 of 2
Year (2015) 3 of 4
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2015-09-18 UDG Healthcare - Pharmaceutical Distribution Division

Israel

UDG Healthcare - Pharmaceutical Distribution Division is a United Drug and United Drug Sangers.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2015-12-15 Belmedis NV

Drongen, Belgium

Belmedis NV is a pharmaceutical and medical equipment distributor in Belgium. The company is based in Drongen, Belgium.

Buy -

Seller(S) 1

SELLER

UDG Healthcare

Dublin, Ireland

website


Category Company
Founded 1948
Sector Business Services
Employees9,000
Revenue 1.3B USD (2020)
DESCRIPTION

UDG Healthcare operates in two segments, Ashfield and Sharp. Ashfield is a global integrated healthcare services partner offering a breadth of services in advisory, marketing, communications, strategic engagement, and patient solutions. Sharp engages in contract packaging, clinical, manufacturing, and technology services. UDG Healthcare was founded in 1948 and is based in Dublin, the Republic of Ireland.


DEAL STATS #
Overall 6 of 8
Sector (Medical Products) 2 of 3
Type (Divestiture) 6 of 8
Country (United Kingdom) 4 of 5
Year (2015) 3 of 3
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2015-09-18 UDG Healthcare - Pharmaceutical Distribution Division

Israel

UDG Healthcare - Pharmaceutical Distribution Division is a United Drug and United Drug Sangers.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2016-10-21 STEM Marketing

London, United Kingdom

STEM Marketing Ltd. is a global provider of commercial, marketing and medical audits to pharmaceutical companies. This unique service uses a proven, evidence based methodology to quantify and benchmark organisational alignment and quality of execution to create practical action plans to accelerate brand performance. STEM is a global business offering services across 35 countries including the US, EU, Japan and China and its customers include 18 of the top 20 largest pharmaceutical companies.

Buy £84M